Experienced in Asphyxia Neonatorum

Axel R. Franz

Tuebingen, BW, DE 
Experienced in Asphyxia Neonatorum
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Axel Franz practices in Tuebingen, Germany. Mr. Franz is rated as an Experienced expert by MediFind in the treatment of Asphyxia Neonatorum. His top areas of expertise are Premature Infant, Necrotizing Enterocolitis, Cerebral Hypoxia, and Infant Respiratory Distress Syndrome.

His clinical research consists of co-authoring 127 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Asphyxia Neonatorum.

Gender
Male

Locations

Tuebingen, BW, Germany
Other Locations
Salem, BW, Germany
Duesseldorf, NW, Germany
Tubingen, Germany
Koeln, NW, Germany
Bonn, NW, Germany
Greifswald, MV, Germany
Ulm, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Feasibility Study - Neofact Feasibility Study of the Application Aid Neofact (Formerly: QuickSF) in the Less Invasive Surfactant Administration (LISA) in Premature Infants With Respiratory Distress Syndrome.
Feasibility Study - Neofact Feasibility Study of the Application Aid Neofact (Formerly: QuickSF) in the Less Invasive Surfactant Administration (LISA) in Premature Infants With Respiratory Distress Syndrome.
Enrollment Status: Completed
Publish Date: November 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
Nahrungsergänzung Mit Cholin- Und Docosahexaensäure Bei Sehr Unreifen Frühgeborenen
Nahrungsergänzung Mit Cholin- Und Docosahexaensäure Bei Sehr Unreifen Frühgeborenen
Enrollment Status: Completed
Publish Date: May 15, 2018
Intervention Type: Dietary supplement
Study Phase: Not Applicable
View 1 Less Clinical Trial

127 Total Publications

Should we abandon ARA and DHA supplementation in preterm infants?
Should we abandon ARA and DHA supplementation in preterm infants?
Journal: Archives of disease in childhood. Fetal and neonatal edition
Published: April 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Franz's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile